Pancreatic Cancer Survival Rate ma kona Kiekie Loa

ʻO ka American Cancer Society's (ACS) Cancer Facts & Figures 2022 hōʻike, i hoʻokuʻu ʻia i kēia lā, e hōʻike ana i ka piʻi ʻana o ka helu ola ʻelima mau makahiki no ka maʻi maʻi pancreatic mai 10 a 11%. ʻO ka manawa hope loa i piʻi ai ka nui o ke ola no ka maʻi maʻi pancreatic ma 2020 i ka wā i hiki mua ai i nā helu pālua.   

ʻOiai ʻo kēia piʻi ʻana o ʻelima mau pākēneka i nā makahiki he ʻumi i hala e hōʻike ana i ka holomua koʻikoʻi, hōʻike ʻia ka hōʻike ʻo Facts & Figures he 62,210 mau ʻAmelika e loaʻa i ka maʻi maʻi pancreatic i 2022, ʻo ia ka piʻi o kahi kokoke i 3% mai ka makahiki i hala. Wahi a ka hōʻike, ʻoiai ʻo ka maʻi maʻi pancreatic i kēia manawa ka 10 o ka maʻi maʻi maʻamau maʻamau i ka US, ʻo ia ke kolu o ke kumu nui o ka make pili i ka maʻi kanesa. Ma kahi o 49,830 ʻAmelika e manaʻo ʻia e make i ka maʻi i kēia makahiki.

Mai kona hoʻokumu ʻia ʻana i ka makahiki 1999, ua hana ka Pancreatic Cancer Action Network (PanCAN) i kahi ala ākea e kūʻē i ka maʻi maʻi paʻakikī loa o ka honua ma nā ʻaoʻao āpau - me ka noiʻi, nā hana lapaʻau, nā lawelawe maʻi a me nā ʻōlelo aʻoaʻo - i mea e hoʻomaikaʻi ai i nā hopena maʻi a hoʻonui i ka holoʻokoʻa. ola ola.

"ʻOliʻoli mākou i ka ʻike ʻana i ka manawa i mua no ka helu ola ʻelima mau makahiki. ʻOiai hoʻokahi hapa pākēneka e hōʻike ana i nā haneli o nā maʻi maʻi maʻi pancreatic e loaʻa hou aku ka manawa me kā lākou poʻe aloha, akā ʻaʻole hiki iā mākou ke hoʻōki i laila, "wahi a Julie Fleshman, JD, MBA, ka pelekikena a me Luna Nui o PanCAN. "ʻO 11% ka helu ola haʻahaʻa loa o nā maʻi maʻi maʻi nui, no laila ke koi wikiwiki nei e hoʻonui i ke kālā, ka noiʻi a me ka ʻike ʻoiai mākou e hana nei e hoʻomaikaʻi hou i nā hopena maʻi."

Ma ka mōʻaukala, ua haʻahaʻa ka helu ola no ka maʻi maʻi pancreatic no ka mea, me ka ʻole o ke ala ʻike mua a me nā hōʻailona pohihihi wale nō, ʻike pinepine ʻia ka lohi i ka wā i laha mua ai ka maʻi. I kēia manawa, ʻaʻole hiki ke ʻoki hou ʻia a aia nā koho lapaʻau chemotherapy i kēia manawa, e hōʻike ana i ka pono wikiwiki no kahi ala ʻike mua no ka maʻi maʻi pancreatic a me nā koho lapaʻau hou a ʻoi aku ka maikaʻi no nā maʻi.

Ke nānā nei i ka wā e hiki mai ana, ua hoʻonohonoho ʻo PanCAN i kahi pahuhopu nui e ʻike i ka piʻi ʻana o ka helu ola ʻelima makahiki i 20% e 2030.

"ʻOiai he lōʻihi kēia pahuhopu, ʻaʻole ia ma waho o ke aupuni o ka hiki," wahi a Lynn Matrisian, PhD, MBA, ka luna ʻepekema nui o PanCAN. "ʻElua mau ala nui e hoʻomaikaʻi ai i ke ola. ʻO kekahi ka ʻike mua. Loaʻa mākou i ka maʻi maʻi ma mua, hāʻawi i ka poʻe i ka manawa hou no ka ʻoki ʻana, ʻoi aku ka nui o nā manawa e mālama ai me nā mea hana chemotherapeutic. ʻO ke ala ʻē aʻe e hoʻomaikaʻi ai mākou i ke ola ʻana ma ka hana ʻana i ka chemotherapy a me nā lāʻau lapaʻau ʻē aʻe.

Mai ka makahiki 2003, ua hoʻolilo ʻo PanCAN ma mua o $149 miliona i ka noiʻi, me kahi $28 miliona hou i manaʻo ʻia i kēia makahiki kālā. Loaʻa kēia i nā haʻawina 218 no nā ʻepekema a puni ka ʻāina a me nā hana noiʻi nui e like me ka PanCAN's Precision PromiseSM Clinical Trial, e ʻimi nei e hoʻolalelale i ka ʻae ʻia o nā koho lapaʻau hou no nā maʻi maʻi maʻi pancreatic a me PanCAN's Early Detection Initiative, e manaʻo nei e hoʻomohala i kahi ka hoʻolālā e ʻike i ka maʻi maʻi pancreatic i ka wā hiki ke hiki ke hana, e alakaʻi ana i nā hopena maʻi maikaʻi aʻe.

No ke kākoʻo ʻana i nā poʻe maʻi maʻi maʻi pancreatic a e hoʻolōʻihi i ka holomua, hāʻawi ʻo PanCAN i ke kākoʻo maʻi maʻi manuahi a pilikino ma o kāna papahana Patient Services, me kahi Clinical Trial Finder e hāʻawi ana i ke komo ʻana i ka ʻikepili hoʻokolohua lapaʻau lapaʻau pancreatic hou loa a piha i ka United States.